Home / Inspections / 1168160

FDA Inspection 1168160 — Novel Laboratories, Inc. d.b.a Lupin Somerset

Novel Laboratories, Inc. d.b.a Lupin Somerset — FEI 3006271438

The FDA completed an inspection of Novel Laboratories, Inc. d.b.a Lupin Somerset on March 30, 2022 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 30, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Facility

Other inspections at this facility

  • 1306616 (VAI Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1285934 (VAI Fri Oct 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1235495 (NAI Fri May 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1197049 (VAI Fri Jan 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1133661 (OAI Thu Nov 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources